Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Verein zur Förderung der Pneumologie am Krankenhaus Großhansdorf is a clinical research association affiliated with the LungenClinic Großhansdorf in Germany. It serves as a specialized center for the planning and execution of clinical trials across all phases (Phase I-IV) in the field of respiratory medicine. The organization focuses on a broad spectrum of pulmonary conditions, including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and interstitial lung diseases. By integrating clinical care with scientific research, the association provides pharmaceutical and biotechnology partners with access to expert investigators and a well-characterized patient base. It operates in close collaboration with the Pneumologisches Forschungsinstitut (PRI) to advance diagnostic and therapeutic innovations. The association is recognized internationally for its contributions to multicenter trials and its role in shaping treatment guidelines for lung diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verein zur Förderung der Pneumologie am Krankenhaus Großhansdorf.